Genprex, Inc.
GNPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $11 | $18 | $12 | $9 |
| G&A Expenses | $0 | $13 | $0 | $0 |
| SG&A Expenses | $11 | $13 | $12 | $12 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21 | $31 | $24 | $21 |
| Operating Income | -$21 | -$31 | -$24 | -$21 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$21 | -$31 | -$24 | -$21 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21 | -$31 | -$24 | -$21 |
| % Margin | – | – | – | – |
| EPS | -266.954 | -1,129 | -990 | -877.5 |
| % Growth | 76.4% | -14% | -12.8% | – |
| EPS Diluted | -266.954 | -1,128 | -990 | -877.5 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$21 | -$31 | -$24 | -$21 |
| % Margin | – | – | – | – |